Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
Obinutuzumab Lymphoma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Leukemia Obinutuzumab Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
octreotide
Odomzo
ofatumumab Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Ofatumumab Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
olanzapine Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting: Common Regimens for Chemotherapy-Induced Nausea and Vomiting
olaparib Olaparib Pancreatic Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Breast Cancer Ovarian Cancer (Epithelial) Prostate Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
olutasidenib Olutasidenib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
omacetaxine
Oncaspar
ondansetron Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Radiation-Induced Nausea and Vomiting: Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting:
Ontak
Opdualag
Orserdu
osimertinib Lung Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Osimertinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
osteogenic sarcoma
ovarian cancer germ cell epithelial
oxaliplatin Biliary Tract Cancer Colorectal Cancer Hepatocellular Cancer Oxaliplatin Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Anal Cancer Cancer of Unknown Primary Esophageal Cancer Lymphoma Pancreatic Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Testicular Cancer
octreotide LAR
omacetaxine mepesuccinate
Oncovin
Onivyde
Opdivo
Orgovyx
OSI-774